Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408

p-ISSN 1735-143X

Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

33 resultsUpdated October 25, 2026

← Back to article

Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure

Digestive and Liver Disease 47(6) (2015)

Alessandro Granito; Sara Marinelli; Eleonora Terzi; Fabio Piscaglia; Matteo Renzulli; Laura Venerandi; Francesca Benevento; Luigi Bolondi

Immunotherapy in hepatocellular carcinoma

Annals of Hepatology 18(2) (2019)

Luigi Buonaguro; Angela Mauriello; Beatrice Cavalluzzo; Annacarmen Petrizzo; Maria Tagliamonte

Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation

Journal of Cancer Research and Clinical Oncology 144(2) (2017)

Franco Trevisani; Giovanni Brandi; Francesca Garuti; Maria Aurelia Barbera; Raffaella Tortora; Andrea Casadei Gardini; Alessandro Granito; Francesco Tovoli; Stefania De Lorenzo; Andrea Lorenzo Inghilesi; Francesco Giuseppe Foschi; Mauro Bernardi; Fabio Marra; Rodolfo Sacco; Giovan Giuseppe Di Costanzo

CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma

Frontiers in Oncology 11 (2021)

Bowen Li; Shibo Wei; Liang Yang; Xueqiang Peng; Yingbo Ma; Bo Wu; Qing Fan; Shuo Yang; Xinyu Li; Hongyuan Jin; Shilei Tang; Mingyao Huang; Hangyu Li; Jingang Liu

Combinatorial immunotherapy strategies for hepatocellular carcinoma

Current Opinion in Immunology 39 (2016)

Maria Tagliamonte; Annacarmen Petrizzo; Maria Lina Tornesello; Gennaro Ciliberto; Franco M. Buonaguro; Luigi Buonaguro

Potentiating cancer vaccine efficacy in liver cancer

OncoImmunology 7(10) (2018)

Maria Tagliamonte; Annacarmen Petrizzo; Angela Mauriello; Maria Lina Tornesello; Franco M. Buonaguro; Luigi Buonaguro

Systemic treatments for hepatocellular carcinoma: challenges and future perspectives

Hepatic Oncology 5(1) (2018)

Francesco Tovoli; Giulia Negrini; Francesca Benevento; Chiara Faggiano; Elisabetta Goio; Alessandro Granito

Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo

Experimental Biology and Medicine 241(13) (2016)

Chia‐Hung Lin; Ching-Yao Chang; Kuan‐Rong Lee; Hui-Ju Lin; Wu-Chou Lin; Ter-Hsin Chen; Lei Wan

A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma

Frontiers in Immunology 13 (2022)

Guanghao Li; Yongheng Liu; Yan-ting Yann Zhang; Yao Xu; Jin Zhang; Xianfu Wei; Zhongmin Zhang; Chao Zhang; Jinyan Feng; Qiang Li; Guowen Wang

An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review

Mini-Reviews in Medicinal Chemistry 22(6) (2021)

Amit Kumar; Ankit Siwach; Prabhakar Kumar Verma

BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis

Cancer Medicine 12(14) (2023)

Hiroyuki Abé; Kenya Kamimura; Shujiro Okuda; Yu Watanabe; Jun Inoue; Yutaka Aoyagi; Toshifumi Wakai; Ryo Kominami; Shuji Terai

The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma

Journal of Oncology 2021 (2021)

Hao Zhang; Renzheng Liu; Lin Sun; Weidong Guo; Xiao Hu

Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Oncology 2021 (2021)

Dongyu Wu; Guangcong Zhang; Jiamei Ma; Hong-Fen Wu; Ju Xiong; Xiaoxi Huang; Yuanyuan Tian; Tao‐Zhi Deng; Xiangyang Han; Xiaoning Sun; Xiang Tian; Xiang‐Nan Yu; Xuemei Jiang

Distribution of Breast Density in Iranian Women and its Association with Breast Cancer Risk Factors

Iranian Red Crescent Medical Journal 15(12) (2013)

Nasrin Ahmadinejad; Sajjadeh Movahedinia; Samaneh Movahedinia; Kourosh Holakouie Naieni; Saharnaz Nejat

Novel Ferrocene Derivatives Induce G0/G1 Cell Cycle Arrest and Apoptosis through the Mitochondrial Pathway in Human Hepatocellular Carcinoma

International Journal of Molecular Sciences 22(6) (2021)

Jianrong Zheng; Liao Zeng; Mingqing Tang; Hongjun Lin; Chao Pi; Ruian Xu; Xiuling Cui

Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology 2021(1) (2021)

Wei Sun; Yongchao Zhang; Bozhi Liu; Youjia Duan; Wei Li; Jinglong Chen

Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma

Science Progress 104(3) (2021)

Jihan Wang; Yangyang Wang; Jing Xu; Qiying Song; Jingbo Shangguan; Mengju Xue; Hanghui Wang; Jingyi Gan; Wenjie Gao

A New CYP2E1 Inhibitor, 12‐Imidazolyl‐1‐dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology 2021(1) (2021)

Torsten Diesinger; Alfred Lautwein; Sebastian Bergler; Dominik Buckert; Christian Renz; Radovan Dvorský; Vyacheslav Buko; Siarhei N. Kirko; Edith M. Schneider; Florian C. Kuchenbauer; Mukesh Kumar; Çagatay Güneş; Felicitas Genze; Berthold Büchele; Thomas Simmet; Martin Haslbeck; Kai Masur; Thomas E. F. Barth; Dieter Müller‐Enoch; Thomas Wirth; Thomas Haehner

Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Journal of Gastrointestinal Cancer 55(4) (2024)

Nandini Gupta; Neelkant Verma; Bhoomika M. Patel

Analysis of the Prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation

Technology in Cancer Research & Treatment 22 (2023)

Renguo Guan; Jie Mei; Rong Guo

RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma

Clinical and Experimental Medicine 22(2) (2021)

Yue Li; Xiaoqin He; Xiaoyu Zhang; Yangtao Xu; Wenliang Chen; Xin Liu; Ximing Xu

Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells

Oncology Letters 17(4) (2019)

Changjiang Lei; Defa Ren; Meixia Fu; Chuantao Sun; Hong Ren; Qingyun Pan; Yuan Li

Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer

Journal of Chemotherapy 37(5) (2024)

Feng Ju; Kaixia Chen; Dengyang Yin

Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology

Clinical Colorectal Cancer 20(3) (2021)

Linda Beenet

Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma

Frontiers in Oncology 11 (2021)

Tin‐Yun Tang; Katherine Daunov; Richard Tsong Lee

Good and Prolonged Response to Low Dose Capecitabine as Second Line Therapy in a Patient with Advanced Hepatocellular Carcinoma

Chemotherapy Open access 05(01) (2015)

Caterina Soldà; Giuseppe Lombardi

ACTR10 Overexpression Facilitates the Progression and Tyrosine Kinase Inhibitor Resistance in Hepatocellular Carcinoma

World Journal of Oncology 15(6) (2024)

Jie Luo; Kai Qin; Rong‐Rong He; Jian Di Li; Zhimin Huang; Bin Yin; Tong Wu; Yongheng Chen; Di Yuan Qin; Jie Luo; Mei Wu; Bang Teng Chi; Gang Chen; Jian Jun Li; Yi Huang

Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience

SpringerPlus 5(1) (2016)

Amr Shaaban Hanafy

Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine

European Journal of Surgical Oncology 47(8) (2021)

Markus Wilhelmi

Ramucirumab and other new systemic therapies for hepatocellular carcinoma: still uncovered the problem of Child-Pugh B patients

Chinese Clinical Oncology 10(3) (2021)